Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Taysha Gene Therapies, Inc. (TSHA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 186,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Taysha Gene Therapies is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. Co. owns the exclusive worldwide rights to a clinical-stage, intrathecally dosed AAV9 gene therapy program, known as TSHA-120, for the treatment of giant axonal neuropathy (GAN). GAN is a rare autosomal recessive disease of the central and peripheral nervous systems caused by loss-of-function gigaxonin gene mutations. TSHA-120 is an AAV9 self-complementary viral vector encoding the full length human gigaxonin protein.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 100,000 17,905,000 19,405,000
Total Buy Value $0 $163,000 $16,186,400 $19,186,400
Total People Bought 0 1 5 5
Total Buy Transactions 0 1 7 8
Total Shares Sold 0 0 582,095 677,095
Total Sell Value $0 $0 $465,624 $813,892
Total People Sold 0 0 2 3
Total Sell Transactions 0 0 7 16
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 59
  Page 2 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Astellas Pharma Inc. 10% Owner   –       –       •   2022-10-21 3 IO $0.00 $0 D/D 0 7,266,342     -
   Alam Kamran Chief Financial Officer   •       –      –    2022-08-23 4 AS $3.47 $11,538 D/D (3,325) 266,121     -
   Alam Kamran Chief Financial Officer   •       –      –    2022-08-22 4 AS $3.50 $34,010 D/D (9,717) 269,446     -
   Alam Kamran Chief Financial Officer   •       –      –    2022-08-19 4 AS $3.75 $43,058 D/D (11,482) 279,163     -
   Alam Kamran Chief Financial Officer   •       –      –    2022-08-18 4 AS $3.87 $28,932 D/D (7,476) 290,645     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2022-07-06 4 AS $3.79 $33,943 D/D (8,956) 530,589     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2022-07-05 4 AS $3.51 $13,707 D/D (3,905) 539,545     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2022-07-01 4 AS $3.53 $84,448 D/D (23,923) 543,450     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2022-06-30 4 AS $3.72 $51,678 D/D (13,892) 567,373     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2022-06-29 4 AS $3.81 $46,954 D/D (12,324) 581,265     -
   Manning Paul B Director   –       •       •   2022-02-03 4 B $7.84 $208,560 I/I 26,602 2,091,704 2.25     -
   Manning Paul B Director   –       •       •   2022-02-03 4 B $7.84 $392,000 D/D 50,000 142,202 3.92     -
   Manning Paul B Director   –       •       •   2022-02-02 4 B $7.77 $520,590 I/I 67,000 22,000 2.25     -
   Manning Paul B Director   –       •       •   2022-02-02 4 B $7.77 $450,660 D/D 58,000 92,202 3.92     -
   Nagendran Sukumar Director   –       •      –    2022-02-02 4 B $8.01 $80,100 D/D 10,000 29,226 2.39     -
   Donenberg Philip B Director   –       •      –    2022-02-02 4 B $7.78 $23,340 D/D 3,000 3,000 2.39     -
   Session R.a. Ii President and CEO   •       •       •   2021-11-23 4 B $12.12 $529,102 D/D 42,518 9,190,920 3.23     -
   Manning Paul B Director   –       •       •   2021-11-23 4 B $12.54 $250,800 D/D 20,000 32,000 3.92     -
   Alam Kamran Chief Financial Officer   •       –      –    2021-08-20 4 AS $16.70 $198,649 D/D (11,840) 298,121     -
   Alam Kamran Chief Financial Officer   •       –      –    2021-08-19 4 AS $16.43 $164,175 D/D (9,967) 309,961     -
   Alam Kamran Chief Financial Officer   •       –      –    2021-08-18 4 AS $17.35 $194,199 D/D (11,193) 319,928     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2021-07-01 4 AS $21.12 $416,191 D/D (19,706) 593,589     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2021-06-30 4 AS $21.42 $437,494 D/D (20,076) 613,295     -
   Prasad Suyash CMO and Head of R&D   •       –      –    2021-06-29 4 AS $23.74 $934,251 D/D (39,218) 633,371     -
   Nolan Sean P. Director   –       •      –    2021-05-20 4 B $22.35 $26,150 D/D 1,170 1,170 2.39     -
  59 Records found
  1  2  3   
  Page 2 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us